Atrophy of the Posterior Subiculum Is Associated with Memory Impairment, Tau- and Aβ Pathology in Non-demented Individuals

被引:31
|
作者
Lindberg, Olof [1 ,2 ]
Martensson, Gustav [2 ]
Stomrud, Erik [1 ]
Palmqvist, Sebastian [1 ]
Wahlund, Lars-Olof [2 ]
Westman, Eric [2 ]
Hansson, Oskar [1 ]
机构
[1] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Lund, Sweden
[2] Karolinska Inst, Div Clin Geriatr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden
来源
基金
瑞典研究理事会; 欧洲研究理事会;
关键词
hippocampus subfield; beta amyloid; subjective cognitive decline; mild cognitive impairment; preclinical AD; MILD COGNITIVE IMPAIRMENT; HIPPOCAMPAL VOLUME REDUCTION; MEDIAL TEMPORAL-LOBE; IN-VIVO MRI; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; CHRONIC-SCHIZOPHRENIA; FUNCTIONAL DOMAINS; MAJOR DEPRESSION; AMYGDALA;
D O I
10.3389/fnagi.2017.00306
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Alzheimer's disease (AD) is associated with atrophy of the cornu ammonis (CA) 1 and the subiculum subfield of the hippocampus (HC), and with deficits in episodic memory and spatial orientation. These deficits are mainly associated with the functionality of the posterior HC. We therefore hypothesized that key AD pathologies, i.e., beta-amyloid and tau pathology would be particularly associated with the volume of the posterior subiculum in non-demented individuals. In our study we included 302 cognitively normal elderly participants (CN), 183 patients with subjective cognitive decline (SCD) and 171 patients with amnestic mild cognitive impairment (MCI), all of whom underwent 3T magnetic resonance images (MRI). The subicular subfield was segmented using Freesurfer 5.3 and divided into 10 volumetric segments moving from the most posterior (segment 1) to the most anterior part along the axis of the hippocampal head and body (segment 10). Cerebrospinal fluid (CSF) A beta(42) and phosphorylated tau (P-tau) were quantified using ELISA and were used as biomarkers for beta-amyloid and tau pathology, respectively. In the total sample, tau-pathology and A beta-pathology and (measured by elevated P-tau and low A beta(42) levels in CSF) and mild memory dysfunction were mostly associated with the volume changes of the posterior subiculum. Both SCD and MCI patients with elevated P-tau or low A beta(42) levels displayed predominantly posterior subicular atrophy in comparisons to control subjects with normal CSF biomarker levels. Finally, there was no main effect of A beta(42) or P-tau when comparing SCD with abnormal P-tau or A beta(42) with SCD with normal levels of these CSF-biomarkers. However, in the left subiculum there was a significant interaction revealing atrophy in the left posterior but not the anterior subiculum in participants with low A beta(42) levels. The same pattern was observed on the contralateral side in participants with elevated P-tau levels. In conclusion, AD pathologies and mild memory dysfunction are mainly associated with atrophy of the posterior parts of the subicular subfields of the HC in non-demented individuals. In light of these findings we suggest that segmentation of the HC subfields may benefit from considering the volume of the different anterior-posterior subsections of each subfield.
引用
收藏
页数:12
相关论文
共 48 条
  • [41] Insomnia associated with lower verbal intelligence and short-term memory performance in non-demented older adults
    Schmutte, T
    Harris, S
    Richard, Z
    Levin, R
    SLEEP, 2005, 28 : A112 - A113
  • [42] Cerebrospinal Fluid Complement 4 Levels Were Associated with Alzheimer's Disease Pathology and Cognition in Non-Demented Elderly
    Zhou, Jie
    Wang, Zhi-Bo
    Sun, Yan
    Fu, Yan
    Li, Da
    Tan, Lan
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 96 (03) : 1071 - 1081
  • [43] Brain hypometabolism in non-demented microtubule-associated protein tau H1 carriers with Parkinson's disease
    Gasca-Salas, Carmen
    Trompeta, Clara
    Lopez-Aguirre, Miguel
    Rojas, Rafael Rodriguez
    Clarimon, Jordi
    Dols-Icardo, Oriol
    El Bounasri, Shaimaa
    Guida, Pasqualina
    Mata-Marin, David
    Hernandez-Fernandez, Frida
    Marras, Connie
    Garcia-Canamaque, Lina
    de las Heras, Isabel Plaza
    Obeso, Ignacio
    Vela, Lydia
    Fernandez-Rodriguez, Beatriz
    JOURNAL OF NEUROIMAGING, 2023, 33 (06) : 953 - 959
  • [44] Hypothalamic Atrophy and Decline in Physical Activity Are Associated with Bone Loss in a Study of Non-Demented Aging and Early Alzheimer's Disease
    Loskutova, Natalia
    Honea, Robyn
    Vidoni, Eric
    Burns, Jeffrey
    NEUROLOGY, 2010, 74 (09) : A215 - A215
  • [45] Associations between plasma neurofilament light, in vivo brain pathology, and cognition in non-demented individuals with autosomal-dominant Alzheimer's disease
    Guzman-Velez, Edmarie
    Zetterberg, Henrik
    Fox-Fuller, Joshua T.
    Vila-Castelar, Clara
    Sanchez, Justin S.
    Baena, Ana
    Garcia-Ospina, Gloria
    Aguillon, David
    Pardilla-Delgado, Enmanuelle
    Gatchel, Jennifer R.
    Sperling, Reisa A.
    Johnson, Keith
    Reiman, Eric M.
    Blennow, Kaj
    Lopera, Francisco
    Quiroz, Yakeel T.
    ALZHEIMERS & DEMENTIA, 2021, 17 (05) : 813 - 821
  • [46] MAPT rs242557 variant is associated with hippocampus tau uptake on 18F-AV-1451 PET in non-demented elders
    Shen, Xue-Ning
    Miao, Dan
    Li, Jie-Qiong
    Tan, Chen-Chen
    Cao, Xi-Peng
    Tan, Lan
    Yu, Jin-Tai
    Weiner, Michael W.
    Aisen, Paul
    Weiner, Michael
    Petersen, Ronald
    Jack, Clifford R., Jr.
    Jagust, William
    Trojanowki, John Q.
    Toga, Arthur W.
    Beckett, Laurel
    Green, Robert C.
    Saykin, Andrew J.
    Morris, John
    Shaw, Leslie M.
    Khachaturian, Zaven
    Sorensen, Greg
    Carrillo, Maria
    Kuller, Lew
    Raichle, Marc
    Paul, Steven
    Davies, Peter
    Fillit, Howard
    Hefti, Franz
    Holtzman, David
    Mesulam, M. Marcel
    Potter, William
    Snyder, Peter
    Lilly, Eli
    Logovinsky, Veronika
    Montine, Tom
    Jimenez, Gustavo
    Donohue, Michael
    Gessert, Devon
    Harless, Kelly
    Salazar, Jennifer
    Cabrera, Yuliana
    Walter, Sarah
    Hergesheimer, Lindsey
    Harvey, Danielle
    Bernstein, Matthew
    Fox, Nick
    Thompson, Paul
    Schuff, Norbert
    DeCArli, Charles
    AGING-US, 2019, 11 (03): : 874 - 884
  • [47] Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial
    Small, Gary W.
    Siddarth, Prabha
    Li, Zhaoping
    Miller, Karen J.
    Ercoli, Linda
    Emerson, Natacha D.
    Martinez, Jacqueline
    Wong, Koon-Pong
    Liu, Jie
    Merrill, David A.
    Chen, Stephen T.
    Henning, Susanne M.
    Satyamurthy, Nagichettiar
    Huang, Sung-Cheng
    Heber, David
    Barrio, Jorge R.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 26 (03): : 266 - 277
  • [48] Head-to-head comparison of tau PET tracers [18F]PI-2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort
    Tonietto, Matteo
    Sotolongo-Grau, Oscar
    Roe-Vellve, Nuria
    Bullich, Santiago
    Tartari, Juan Pablo
    Sanabria, Angela
    Garcia-Sanchez, Ainhoa
    Borroni, Edilio
    Galli, Christopher
    Perez-Martinez, Esther
    Castell-Conesa, Joan
    Roca, Isabel
    Tarraga, Lluis
    Ruiz, Agustin
    Stephens, Andrew W.
    Boada, Merce
    Klein, Gregory
    Marquie, Marta
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)